Avesthagen partners with ShigaMediX to develop vaccines for cervical cancer and tuberculosis

AVESTHAGEN LIMITED recently signed a Letter of Intent with Paris based ShigaMediX SAS.

Mumbai, Maharashtra, April 25, 2008 /India PRwire/ -- India’s leading knowledge based Life Sciences Company, Avesthagen Limited recently signed a Letter of Intent with Paris based ShigaMediX SAS. The partnership will result in developing a novel therapeutic vaccine against HPV (Human Papilloma Virus), which causes cervical cancer. Researchers have found that this accounts for an estimated 24% of India’s cancer cases in women and approximately 130,000 new cases annually across the globe.

Therapeutic vaccines are products that treat existing disease conditions and will be developed using ShigaMedix’s Antigen Vector System technology. The system targets the antigen presenting dendritic cells through the coupling of Shiga Toxin and HPV 16 / E 7 complex. Recent studies on animals have shown it to be effective in clearing the HPV induced tumor cells.

A similar technology will be used to develop an STxB – TB vaccine.

Avesthagen and ShigaMediX will co-develop this technology in both France and India through the Proof of Concept and would share the costs and rewards on an equal basis’ said Dr. Villoo Morawala-Patell, Founder and CMD, Avesthagen Limited on signing the Letter of Intent.

The companies are in the final stages of concluding the Co-development and licensing agreement, which will be signed in the coming weeks.

Notes to Editor

About Avesthagen Limited

Avesthagen Limited is India’s leading integrated systems biology platform company that focuses on achieving convergence of food, pharma and population genetics leading to predictive preventive and personalized healthcare. It employs 600 people worldwide and is headquartered in Bangalore. Avesthagen Limited has established world class, state-of-the-art laboratory facilities in Bangalore. It began business operations in 2001.Since its inception Avesthagen has grown into one of India's leading healthcare technology group in India, and its activities include, in addition to its agri-biotechnologies product pipeline, development of clinically validated botanical bioactives, derived from Indian medicinal plants, as well as the development of a pipeline of bio-similar drugs. Avesthagen Limited has four strategic business units: bioPharmaceuticals, bioNutrition, bioAgriculture and Science & Innovation. Its partners include multiple top 10 global companies in each of its fields of research. Avesthagen Limited collaborates at every stage in the value chain with appropriate partners, both public and private, for access to and exchange of technology and overall commercial expertise to leverage the ‘India advantage’.

Visit us at: www.avesthagen.com

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.

Imprimis Life PR recent press release(s)

Dr. Villoo Morawala-Patell receives 'Top French Award'

French government bestowed the award of Officier de L'Ordre National du Mérite (Officer of the National Order of Merit) on Dr. Villoo Morawala - Patell, Founder, CMD of AVESTHAGEN LIMITED

Dabur Pharma signs agreement with Government Pharmaceutical Organization, Thailand for Cost Effective Anticancer Product

Announcement of agreement with GPO

Avesthagen Limited and Limagrain Introduce India's First 100% Biodegradable Plastic

Companies Further Strengthen Their Partnership With The Launch Of This Innovative Product

Avesthagen Limited And DuBiotech To Enter Into A Joint Venture

Launch and commercialization of BioPercept, an eco-friendly and biodegradable plastic in the Gulf Cooperation Council (GCC) region and also establish a conversion plant to process BioPercept within the next two years. This alternate biodegradable plastic breaks down and becomes compost in a matter of 120 days under industrial composting conditions.

BASF's global programme Kids' Lab set to enthrall Mumbai

A first-of-its kind hands-on lab experience for kids on board the Science Express To be hosted in the city from April 4th to April 8th